Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$230K Sell
5,645
-254
-4% -$11K 0.05% 108
2022
Q4
$302K Buy
5,899
+535
+10% +$25.6K 0.08% 98
2022
Q3
$235K Hold
5,364
0.07% 97
2022
Q2
$281K Hold
5,364
0.08% 98
2022
Q1
$278K Buy
5,364
+475
+10% +$24.6K 0.06% 110
2021
Q4
$289K Buy
4,889
+206
+4% +$10.2K 0.06% 104
2021
Q3
$201K Buy
+4,683
New +$207K 0.04% 117
2020
Q4
Sell
-6,196
Closed -$216K 124
2020
Q3
$216K Buy
+6,196
New +$217K 0.05% 116
2020
Q1
Sell
-5,880
Closed -$219K 134
2019
Q4
$219K Hold
5,880
0.07% 105
2019
Q3
$200K Buy
5,880
+326
+6% +$11.9K 0.07% 109
2019
Q2
$228K Hold
5,554
0.08% 100
2019
Q1
$224K Buy
+5,554
New +$222K 0.09% 101
2018
Q3
Sell
-10,379
Closed -$357K 109
2018
Q2
$357K Buy
10,379
+664
+7% +$22.7K 0.16% 73
2018
Q1
$327K Hold
9,715
0.14% 75
2017
Q4
$334K Sell
9,715
-468
-5% -$16K 0.15% 75
2017
Q3
$345K Sell
10,183
-574
-5% -$18.4K 0.15% 72
2017
Q2
$343K Buy
10,757
+586
+6% +$18.5K 0.14% 70
2017
Q1
$330K Buy
10,171
+5
+0% +$158 0.13% 71
2016
Q4
$313K Sell
10,166
-2,449
-19% -$74.8K 0.13% 74
2016
Q3
$405K Buy
12,615
+564
+5% +$18.9K 0.15% 74
2016
Q2
$403K Sell
12,051
-3,033
-20% -$96.8K 0.16% 73
2016
Q1
$420K Sell
15,084
-1,216
-7% -$34.7K 0.16% 77
2015
Q4
$499K Sell
16,300
-32
-0.2% -$1.01K 0.2% 70
2015
Q3
$487K Sell
16,332
-3,246
-17% -$104K 0.26% 55
2015
Q2
$623K Buy
19,578
+18,897
+2,775% +$616K 0.34% 45
2015
Q1
$18.6K Buy
+681
New +$21.7K 0.28% 36

Other funds holding PFE

Domani Wealth's PFE Position: Q1 2023 in Review

Domani Wealth reduced its Pfizer (PFE) stake by 4.3% in Q1 2023, selling an estimated $11K and leaving 5,645 shares worth $230K. The position accounts for 0.05% of the portfolio, ranked #108.

Domani Wealth first reported a position in PFE in Q1 2015 and has held it in 26 quarters since. The position peaked at $623K in Q2 2015. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Domani Wealth held 5,645 shares of Pfizer worth $230K as of Q1 2023.
  • Domani Wealth sold 254 Pfizer shares in Q1 2023, an estimated $11K.
  • Pfizer made up 0.05% of Domani Wealth's portfolio in Q1 2023, its #108 holding.
  • Domani Wealth first reported a position in Pfizer in Q1 2015 and has held it in 26 quarters since.
  • Domani Wealth's Pfizer position peaked at $623K in Q2 2015.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Domani Wealth's 13F filing for Q1 2023, filed 19 Apr 2023.